Results 21 to 30 of about 7,787,676 (175)

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact [PDF]

open access: yes, 2013
Background Estimation of pre-immunisation prevalence of HPV and distribution of HPV types is fundamental to understanding the subsequent impact of HPV vaccination.
Robertson, Charles   +8 more
core   +4 more sources

Pilot Study

open access: yesJournal of Primary Care & Community Health, 2012
Background: Despite approval of a vaccine found to be very effective in preventing human papillomavirus infection and related cancers, many young people have not yet been vaccinated.
Carolyn J. Heckman   +2 more
doaj   +1 more source

Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. [PDF]

open access: yes, 2006
Human papillomavirus (HPV) infection and cervical squamous intraepithelial lesions (SILs) were studied in 379 high-risk women. Human papillomavirus DNA was detected in 238 of 360 (66.1%) of the beta-globin-positive cervical samples, and 467 HPV isolates ...
Costes-Martineau, V   +30 more
core   +1 more source

Plant production and immunogenic characterisation of Human papillomavirus chimaeric vaccines [PDF]

open access: yes, 2011
Includes abstract.Includes bibliographical references (leaves 153-175).Cervical cancer is primarily caused by infection with Human papillomavirus (HPV) and is a global concern, particularly in developing countries which contain ~80% of the cervical ...
Pineo, Catherine
core   +1 more source

Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. [PDF]

open access: yes, 2012
BACKGROUND: There are few data on factors influencing human papillomavirus (HPV) vaccination uptake in sub-Saharan Africa. We examined the characteristics of receivers and non-receivers of HPV vaccination in Tanzania and identified reasons for not ...
Soteli, Selephina   +21 more
core   +1 more source

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

open access: yesHealth Technology Assessment, 2020
Background: The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, USA ...
Richard Gilson   +14 more
doaj   +1 more source

Detection and genotyping of human Papillomavirus in urine samples from unvaccinated male and female adolescents in Italy [PDF]

open access: yes, 2013
The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to ...
Zotti, CM   +93 more
core   +2 more sources

Understanding How Adolescents Think about the HPV Vaccine

open access: yesVaccines, 2020
Despite educational efforts, Tennessee human papillomavirus (HPV) vaccination rates are 43%, among the lowest in the United States. This study examined how adolescents think about the HPV vaccine to identify patterns and misconceptions to enhance ...
Robyn A. Pennella   +2 more
doaj   +1 more source

Therapeutic dendritic cell vaccination against human papillomavirus [PDF]

open access: yes, 2009
Cervical cancer, which is caused by infection with human papillomavirus (HPV), is the second most common cancer among women worldwide, leading to 230000 deaths annually.
Nurkkala Karlsson, Merja
core   +1 more source

Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes [PDF]

open access: yes, 2001
Canine oral papillomavirus (COPV) infection is used in vaccine development against mucosal papillomaviruses. The predictable, spontaneous regression of the papillomas makes this an attractive system for analysis of cellular immunity.
Nicholls, Philip K.   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy